Xconomy: Bill Gates Backs Nimbus, Betting on Computer-Based Drug Discovery
Summary
Bill Gates Backs Nimbus, Betting on Computer-Based Drug Discovery Xconomy Boston — Here’s a startup that is stepping out of top-secret status in style.Microsoft Chairman Bill Gates, the second-most wealthy person in the world, is one of two new seed investors in the stealthy biotech startup, Nimbus Discovery.And Gates was a major investor and board member of the Bothell, WA-based biotech firm Icos, which developed the erectile dysfunction drug tadalafil (Cialis) and was acquired by Eli Lilly (NYSE:LLY) for $2.1 billion in 2007.Early this week, my colleague Luke Timmerman also reported the Gates Foundation put together its first direct equity investment in a biotech company, through a $10 million financing of Research Triangle Park, NC-based Liquidia Technologies.Later, the drugs can be formulated into actual chemical compounds and tested in laboratory experiments to confirm insights from the software, explained Jonathan Montagu, the vice president of business operations at Nimbus.
Classifications
AskAI Classifications
LabelsLinked Companies
